Related Experiment Video
Updated: May 28, 2026

09:46
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Platelet dysfunction in acute leukemias and myelodysplastic syndromes
Summary
Hemorrhagic and thrombotic complications are common in myelodysplastic syndromes and acute leukemias. Platelet count and function, including glycoprotein changes, significantly impact these bleeding and clotting disorders.
Area of Science:
- Hematology
- Oncology
Background:
- Hemorrhagic and thrombotic diathesis frequently complicate myelodysplastic syndromes (MDS) and acute leukemias.
- These complications are linked to platelet count and qualitative platelet disorders.
Discussion:
- Platelet membrane glycoprotein alterations are key qualitative defects.
- Advanced platelet studies, such as flow cytometry, can reveal these changes.
- Modified platelet activation, secretion, and aggregation patterns are observed.
Key Insights:
- Platelet qualitative disorders, specifically membrane glycoprotein changes, are crucial in MDS and acute leukemia complications.
- Flow cytometry is a valuable tool for identifying these platelet abnormalities.
- Altered platelet function (activation, secretion, aggregation) is a direct consequence of these molecular changes.
Outlook:
- Further research into specific glycoprotein targets may lead to novel therapeutic strategies.
- Understanding these platelet defects can improve patient risk stratification and management.
- Developing targeted therapies for platelet dysfunction could mitigate bleeding and thrombotic events.
Related Concept Videos
Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

